Select a Size
| Size/SKU | Availability | Price |
|---|
About This Item
grade
pharmaceutical primary standard
agency
USP
API family
lorazepam
manufacturer/tradename
USP
drug control
USDEA Schedule I; regulated under CDSA - not available from Sigma-Aldrich Canada; psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal); Pszichotróp anyag / Psychotropic Substance (Hungary), 78/2022. (XII. 28.) BM rendelet, kontrollierte Droge in Deutschland
application(s)
pharmaceutical (small molecule)
format
neat
SMILES string
OC1N=C(c2ccccc2Cl)c3cc(Cl)ccc3NC1=O
InChI
1S/C15H10Cl2N2O2/c16-8-5-6-12-10(7-8)13(19-15(21)14(20)18-12)9-3-1-2-4-11(9)17/h1-7,15,21H,(H,18,20)
InChI key
DIWRORZWFLOCLC-UHFFFAOYSA-N
Gene Information
General description
Application
- Lorazepam Injection
- Lorazepam Oral Concentrate
- Lorazepam Tablets
Analysis Note
Other Notes
Legal Information
Dieses Produkt fällt unter das Betäubungsmittelgesetz (BtMG). Für eine Bestellung dieses Produktes ist eine Erlaubnis nach § 3 BtMG zwingend erforderlich, es sei denn, es greift eine Ausnahme von der Erlaubnispflicht nach § 4 oder § 26 BtMG.
English
This product is subject to the German Narcotics Act. A permit under Section 3 of the German Narcotics Act is mandatory for ordering this product unless an exemption from the permit requirement under Section 4 or Section 26 of the German Narcotics Act applies.
1 of 1
This Item | |||
|---|---|---|---|
| manufacturer/tradename USP | manufacturer/tradename - | manufacturer/tradename - | manufacturer/tradename Cerilliant® |
| grade pharmaceutical primary standard | grade - | grade certified reference material, pharmaceutical secondary standard | grade certified reference material |
| format neat | format - | format - | format single component solution |
| application(s) pharmaceutical (small molecule) | application(s) - | application(s) pharmaceutical | application(s) clinical testing |
| drug control USDEA Schedule I; regulated under CDSA - not available from Sigma-Aldrich Canada; psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal); Pszichotróp anyag / Psychotropic Substance (Hungary), 78/2022. (XII. 28.) BM rendelet, kontrollierte Droge in Deutschland | drug control USDEA Schedule IV; Home Office Schedule 4.1; psychotrope (France); kontrollierte Droge in Deutschland; regulated under CDSA - not available from Sigma-Aldrich Canada; psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal); Pszichotróp anyag / Psychotropic Substance (Hungary), 78/2022. (XII. 28.) BM rendelet | drug control - | drug control - |
| API family lorazepam | API family - | API family lorazepam | API family - |
Still not finding the right product?
Explore all of our products under Lorazepam
signalword
Warning
hcodes
Hazard Classifications
Repr. 2
Storage Class
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.


